A detailed history of Integras Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Integras Partners LLC holds 48,139 shares of BMY stock, worth $2.09 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares
48,139
Previous 48,560 0.87%
Holding current value
$2.09 Million
Previous $2.96 Billion 24.76%
% of portfolio
2.24%
Previous 2.67%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

SELL
$44.12 - $59.6 $18,574 - $25,091
-421 Reduced 0.87%
48,139 $2.23 Billion
Q1 2025

May 14, 2025

SELL
$53.9 - $63.11 $27,650 - $32,375
-513 Reduced 1.05%
48,560 $2.96 Billion
Q4 2024

Feb 10, 2025

BUY
$51.92 - $59.94 $2.55 Million - $2.94 Million
49,073 New
49,073 $2.78 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $92.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Integras Partners LLC Portfolio

Follow Integras Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integras Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integras Partners LLC with notifications on news.